"No attributes have been selected. Adding attributes will make it easier for your customer and patients to find you online."

During the past decade, Advocate Medical Group - Midwest Heart Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Advocate Medical Group - Midwest Heart Foundation" are "Congestive Heart Failure" (1 trials), "Left Ventricular (LV) Systolic Dysfunction" (1 trials), "NYHA Class III Heart Failure" (1 trials) and "NYHA Class IV Heart Failure" (1 trials). Many other conditions were trialed in "Advocate Medical Group - Midwest Heart Foundation" in a lesser frequency.

Most popular intervention types in "Advocate Medical Group - Midwest Heart Foundation" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)" (1 trials), "No intervention: Optimal medical therapy" (1 trials) and "Optimizer System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advocate Medical Group - Midwest Heart Foundation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Advocate Medical Group - Midwest Heart Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Advocate Medical Group - Midwest Heart Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advocate Medical Group - Midwest Heart Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".